Neurofibromatosis Research Helping Scientists to Understand Autism
People with neurofibromatosis type 1 have a higher incidence of many different complications. Tumor growth and learning disabilities are especially…
Read MoreCheck out past blogs and news!
People with neurofibromatosis type 1 have a higher incidence of many different complications. Tumor growth and learning disabilities are especially…
Read MoreThis newsletter published in March 2015 includes, but is not limited to… The announcement of NF Midwest’s new Scholarship Fund;…
Read MoreThe NF Midwest Board has voted to start a Scholarship Program with funds left to NF Midwest through a charitable…
Read MoreAt our annual symposium on October 25, 2014 Long-Sheng Chang, Phd from The Research Institute at Nationwide Children’s Hospital and…
Read MoreThank you to the Neuro Foundation of London for putting together a very informative and short video on MPNSTs (Malignant…
Read MoreWe are very excited to have two new warm and passionate bodies join the NF Midwest board last fall. Ellen…
Read MoreAt NF Midwest’s annual symposium in October 2014 we invited Eva Dombi, MD, from the National Cancer Institute to present…
Read MoreDr. Maria Acosta at Children’s National Medical Center is looking for parents of children with Neurofibromatosis Type 1 in which…
Read MoreNF Midwest has previously funded studies by Dr. Klein-Tasman’s team that has resulted in valuable information on the cognitive abilities…
Read MoreAt our annual symposium on October 25, 2014 Dr. Parag Shah of Lurie Children’s Hospital and LaRabida Children’s Hospital spoke on…
Read More
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.